Tarsus Pharmaceuticals, Inc.
TARSDrugs in Pipeline
6
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
Aug 5, 2026
7dMarket Overview
Stock performance and key metrics
1 upcoming, 0 past
TARS Earnings Report
EPS Est: $-0.21 | FQ end 2026-06
How TARS's past catalysts played out
TP-03 Vehicle
Blepharitis
TP-03, 0.25%
Blepharitis
TP-03
Meibomian Gland Dysfunction
Lotilaner Gel, 2.0%
Papulopustular Rosacea
Low Dose TP-05
Healthy Volunteer
TP-05 (lotilaner) Low Dose
Lyme Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
TP-03 Vehicle | Phase 3 | Blepharitis | - | - |
TP-03, 0.25% | Phase 3 | Blepharitis | - | - |
TP-03 | Phase 3 | Meibomian Gland Dysfunction | - | - |
Lotilaner Gel, 2.0% | Phase 2 | Papulopustular Rosacea | - | - |
Low Dose TP-05 | Phase 2 | Healthy Volunteer | - | - |
TP-05 (lotilaner) Low Dose | Phase 2 | Lyme Disease | - | - |
Blepharitis
2 drugs in this indication
Meibomian Gland Dysfunction
2 drugs in this indication
Healthy Volunteer
1 drug in this indication
Papulopustular Rosacea
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Tarsus Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 6 drug candidates in Tarsus Pharmaceuticals, Inc.'s (TARS) pipeline across Phase 3, Phase 2. Its lead program is TP-03 Vehicle (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Tarsus Pharmaceuticals, Inc.'s next FDA catalyst?→
Tarsus Pharmaceuticals, Inc.'s (TARS) next tracked catalyst is a Earnings expected August 5, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TARS biotech catalysts?→
Add TARS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Tarsus Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.